{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:48:41Z","timestamp":1787759321567,"version":"build-2784847793"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s15010-026-02726-w","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T13:17:28Z","timestamp":1775222248000},"page":"1063-1075","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of Gepotidacin for urogenital infections: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8717-6108","authenticated-orcid":false,"given":"Ashesh","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umama","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akif Shahid","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debvarsha","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sailesh I. S.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kommu","family":"Hrishikesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Malireddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanisha Reddy","family":"Kukunoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata Dileep Kumar","family":"Veldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Naseem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asim Ali","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"issue":"4","key":"2726_CR1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/ndt\/gfad233","volume":"39","author":"S Von Vietenghoff","year":"2024","unstructured":"Von Vietenghoff S, Shevchuk O, Dobrindt U, Engel DR, Jorch SK, Kurts C, et al. The global burden of antimicrobial resistance\u2014urinary tract infections. Nephrol Dial Transplant. 2024;39(4):581\u20138. https:\/\/doi.org\/10.1093\/ndt\/gfad233.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"2726_CR2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/life14010106","volume":"14","author":"C Mares","year":"2024","unstructured":"Mares C, Petca RC, Popescu RI, Petca A, Multescu R, Bulai CA, et al. Update on urinary tract infection antibiotic resistance\u2014a retrospective study in females in conjunction with clinical data. Life Basel. 2024;14(1):106. https:\/\/doi.org\/10.3390\/life14010106.","journal-title":"Life Basel"},{"issue":"1","key":"2726_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40779-024-00569-w","volume":"11","author":"H Zi","year":"2024","unstructured":"Zi H, Liu MY, Luo LS, Huang Q, Luo PC, Luan HH, et al. Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021. Mil Med Res. 2024;11(1):64. https:\/\/doi.org\/10.1186\/s40779-024-00569-w.","journal-title":"Mil Med Res"},{"key":"2726_CR4","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.UTI-0002-2012","author":"SE Geerlings","year":"2016","unstructured":"Geerlings SE. Clinical presentations and epidemiology of urinary tract infections. Microbiol Spectr. 2016. https:\/\/doi.org\/10.1128\/microbiolspec.UTI-0002-2012.","journal-title":"Microbiol Spectr"},{"issue":"1","key":"2726_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41572-019-0128-6","volume":"5","author":"M Unemo","year":"2019","unstructured":"Unemo M, Seifert HS, Hook EW 3rd, Hawkes S, Ndowa F, Dillon JR. Gonorrhoea. Nat Rev Dis Primers. 2019;5(1):79. https:\/\/doi.org\/10.1038\/s41572-019-0128-6.","journal-title":"Nat Rev Dis Primers"},{"issue":"20","key":"2726_CR6","first-page":"V01180041","volume":"180","author":"J Tolstrup","year":"2018","unstructured":"Tolstrup J, Westh H, Vestergaard T. Gonorrhoea. Ugeskr Laeger. 2018;180(20):V01180041 (Danish)","journal-title":"Ugeskr Laeger"},{"issue":"1","key":"2726_CR7","doi-asserted-by":"publisher","first-page":"106018","DOI":"10.1016\/j.ijantimicag.2020.106018","volume":"56","author":"T Wang","year":"2020","unstructured":"Wang T, Wu G, Wang J, Cui Y, Ma J, Zhu Z, et al. Comparison of single dose fosfomycin tromethamine and other antibiotics for lower uncomplicated urinary tract infection in women and asymptomatic bacteriuria in pregnant women: a systematic review and meta-analysis. Int J Antimicrob Agents. 2020;56(1):106018. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106018.","journal-title":"Int J Antimicrob Agents"},{"issue":"13","key":"2726_CR8","doi-asserted-by":"publisher","first-page":"10537","DOI":"10.3390\/ijms241310537","volume":"24","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Zhou Z, Zheng L, Gong Z, Li Y, Jin Y, et al. Urinary tract infections caused by uropathogenic Escherichia coli: mechanisms of infection and treatment options. Int J Mol Sci. 2023;24(13):10537. https:\/\/doi.org\/10.3390\/ijms241310537.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2726_CR9","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.47391\/JPMA.7616","volume":"73","author":"TM Tariq","year":"2023","unstructured":"Tariq TM. Frequency of uropathogens showing resistance to nitrofurantoin. J Pak Med Assoc. 2023;73(7):1495\u20137. https:\/\/doi.org\/10.47391\/JPMA.7616.","journal-title":"J Pak Med Assoc"},{"key":"2726_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/978-1-4939-9496-0_3","volume":"1997","author":"M Unemo","year":"2019","unstructured":"Unemo M, Golparian D, Eyre DW. Antimicrobial resistance in Neisseria gonorrhoeae and treatment of gonorrhoea. Methods Mol Biol. 2019;1997:37\u201358. https:\/\/doi.org\/10.1007\/978-1-4939-9496-0_3.","journal-title":"Methods Mol Biol"},{"issue":"5","key":"2726_CR11","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1093\/jac\/dkad060","volume":"78","author":"RR Watkins","year":"2023","unstructured":"Watkins RR, Thapaliya D, Lemonovich TL, Bonomo RA. Gepotidacin: a novel, oral, \u2018first-in-class\u2019 triazaacenapthylene antibiotic for the treatment of uncomplicated urinary tract infections and urogenital gonorrhoea. J Antimicrob Chemother. 2023;78(5):1137\u201342. https:\/\/doi.org\/10.1093\/jac\/dkad060.","journal-title":"J Antimicrob Chemother"},{"issue":"10428","key":"2726_CR12","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0140-6736(23)02196-7","volume":"403","author":"F Wagenlehner","year":"2024","unstructured":"Wagenlehner F, Perry CR, Hooton TM, Scangarella-Oman NE, Millns H, Powell M, et al. Oral gepotidacin versus nitrofurantoin in patients with uncomplicated urinary tract infection (EAGLE-2 and EAGLE-3): two randomised, controlled, double-blind, double-dummy, phase 3, non-inferiority trials. Lancet. 2024;403(10428):741\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(23)02196-7.","journal-title":"Lancet"},{"issue":"2","key":"2726_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.5582\/ddt.2025.01028","volume":"19","author":"S Hu","year":"2025","unstructured":"Hu S, Yu H, Gao J. Gepotidacin: the first-in-class triazaacenaphthylene antibiotic approved for the treatment of uncomplicated urinary tract infections. Drug Discov Ther. 2025;19(2):129\u201330. https:\/\/doi.org\/10.5582\/ddt.2025.01028.","journal-title":"Drug Discov Ther"},{"issue":"4","key":"2726_CR14","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/cid\/ciy145","volume":"67","author":"SN Taylor","year":"2018","unstructured":"Taylor SN, Morris DH, Avery AK, Workowski KA, Batteiger BE, Tiffany CA, et al. Gepotidacin for the treatment of uncomplicated urogenital gonorrhoea: a phase 2, randomized, dose-ranging, single-oral dose evaluation. Clin Infect Dis. 2018;67(4):504\u201312. https:\/\/doi.org\/10.1093\/cid\/ciy145.","journal-title":"Clin Infect Dis"},{"key":"2726_CR15","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nature09197","volume":"466","author":"BD Bax","year":"2010","unstructured":"Bax BD, Chan PF, Eggleston DS, et al. Type IIA topoisomerase inhibition by a new class of antibacterial agents. Nature. 2010;466:935\u201340. https:\/\/doi.org\/10.1038\/nature09197.","journal-title":"Nature"},{"key":"2726_CR16","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1128\/AAC.02820-15","volume":"60","author":"DJ Biedenbach","year":"2016","unstructured":"Biedenbach DJ, Bouchillon SK, Hackel M, et al. In vitro activity of gepotidacin, a novel triazaacenapthylene bacterial topoisomerase inhibitor, against a broad spectrum of bacterial pathogens. Antimicrob Agents Chemother. 2016;60:1918\u201323.","journal-title":"Antimicrob Agents Chemother"},{"key":"2726_CR17","unstructured":"Tiffany CA, Hossein M, McDonald M, Lerman S, Dumont EF. Safety and pharmacokinetics of single escalating IV doses of GSK2140944, a novel bacterial topoisomerase inhibitor [abstract F-278]. Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC: American Society for Microbiology, 2014."},{"issue":"6","key":"2726_CR18","doi-asserted-by":"publisher","first-page":"e02095","DOI":"10.1128\/AAC.02095-16","volume":"61","author":"W O\u2019Riordan","year":"2017","unstructured":"O\u2019Riordan W, Tiffany C, Scangarella-Oman N, Perry C, Hossain M, Ashton T, et al. Efficacy, safety, and tolerability of gepotidacin (GSK2140944) in the treatment of patients with suspected or confirmed Gram-positive acute bacterial skin and skin structure infections. Antimicrob Agents Chemother. 2017;61(6):e02095\u2013116. https:\/\/doi.org\/10.1128\/AAC.02095-16.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10489","key":"2726_CR19","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/S0140-6736(25)00628-2","volume":"405","author":"JDC Ross","year":"2025","unstructured":"Ross JDC, Brittain C, Cole M, Del Rosario-Quintana C, Jacobsson S, Tideman RL, et al. Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open label, non-inferiority, multicentre study. Lancet. 2025;405(10489):1608\u201320. https:\/\/doi.org\/10.1016\/S0140-6736(25)00628-2.","journal-title":"Lancet"},{"key":"2726_CR20","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions | Cochrane Training. https:\/\/training.cochrane.org\/handbook. Accessed 11 Jan 2025."},{"key":"2726_CR21","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JA Sterne","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"key":"2726_CR22","doi-asserted-by":"publisher","first-page":"100605","DOI":"10.1016\/j.obmed.2025.100605","volume":"55","author":"A Afridi","year":"2025","unstructured":"Afridi A, Henna F, Cheema U, Sehar A, Rana MFI, Dar A, et al. Efficacy and safety of liraglutide in pediatric obesity: A systematic review and meta-analysis of randomized controlled trials. Obes Med. 2025;55:100605. https:\/\/doi.org\/10.1016\/j.obmed.2025.100605","journal-title":"Obes Med"},{"issue":"7414","key":"2726_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"issue":"3","key":"2726_CR24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388.","journal-title":"Control Clin Trials"},{"issue":"3","key":"2726_CR25","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1128\/AAC.02820-15","volume":"60","author":"DJ Biedenbach","year":"2016","unstructured":"Biedenbach DJ, Bouchillon SK, Hackel M, et al. In vitro activity of gepotidacin, a novel bacterial topoisomerase inhibitor, against a broad spectrum of bacterial pathogens. Antimicrob Agents Chemother. 2016;60(3):1918\u201323.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"2726_CR26","first-page":"897","volume":"18","author":"LA Barbee","year":"2020","unstructured":"Barbee LA. Preparing for antibiotic-resistant gonorrhea: lessons learned from prior treatment failures. Expert Rev Anti Infect Ther. 2020;18(10):897\u2013904.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"4","key":"2726_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","volume":"70","author":"KA Workowski","year":"2021","unstructured":"Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1\u2013187.","journal-title":"MMWR Recomm Rep"},{"issue":"9","key":"2726_CR28","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1128\/AAC.02955-14","volume":"58","author":"CA Tiffany","year":"2014","unstructured":"Tiffany CA, Hossein M, McDonald M, Lerman S, Dumont EF. Safety and pharmacokinetics of single escalating IV doses of gepotidacin: results from a phase 1 study. Antimicrob Agents Chemother. 2014;58(9):5136\u201343.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"2726_CR29","doi-asserted-by":"publisher","first-page":"e02095-16","DOI":"10.1128\/AAC.02095-16","volume":"61","author":"W O\u2019Riordan","year":"2017","unstructured":"O\u2019Riordan W, Tiffany C, Scangarella-Oman N, et al. Efficacy, safety, and tolerability of gepotidacin in Gram-positive acute skin infections. Antimicrob Agents Chemother. 2017;61(6):e02095-16.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"2726_CR30","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1071\/SH19023","volume":"16","author":"M Unemo","year":"2019","unstructured":"Unemo M, Lahra MM, Cole M, Galarza P, Ndowa F, Martin I, et al. World Health Organization global gonococcal antimicrobial surveillance program: review of new data and future directions. Sex Health. 2019;16(5):412\u201325.","journal-title":"Sex Health"},{"issue":"4","key":"2726_CR31","first-page":"486","volume":"19","author":"DW Eyre","year":"2019","unstructured":"Eyre DW, Sanderson ND, Lord E, Regisford-Reimmer N, Chau K, Barker L, et al. Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance. Lancet Infect Dis. 2019;19(4):486\u201393.","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"2726_CR32","doi-asserted-by":"publisher","first-page":"e1002344","DOI":"10.1371\/journal.pmed.1002344","volume":"14","author":"T Wi","year":"2017","unstructured":"Wi T, Lahra MM, Ndowa F, Bala M, Dillon JR, Ramon-Pardo P, et al. Antimicrobial resistance in Neisseria gonorrhoeae: global surveillance and a call for international collaborative action. PLoS Med. 2017;14(7):e1002344.","journal-title":"PLoS Med"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-02726-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-026-02726-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-02726-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:44:38Z","timestamp":1782920678000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-026-02726-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2726"],"URL":"https:\/\/doi.org\/10.1007\/s15010-026-02726-w","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}